|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 55.7 TWD | -0.36% |
|
+10.08% | -4.30% |
TCM Biotech International Corp. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was TWD 802.42 million compared to TWD 702.05 million a year ago.
Net income was TWD 18.27 million compared to TWD 1.87 million a year ago. Basic earnings per share from continuing operations was TWD 0.3687 compared to TWD 0.0388 a year ago. Diluted earnings per share from continuing operations was TWD 0.3687 compared to TWD 0.0388 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -4.30% | 101M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
TCM BIOTECH INTERNATIONAL CORP. 
